ArticleThe Journal of biological chemistry2014

The diabetes drug target MitoNEET governs a novel trafficking pathway to rebuild an Fe-S cluster into cytosolic aconitase/iron regulatory protein 1.

Ioana Ferecatu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.